IMRX - Immuneering Corp
Immuneering Corp Logo

IMRX - Immuneering Corp

https://immuneering.com
Momentum: Bearish
Recent News
Powered by Alpha Vantage

No recent news found.

AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot

None

52W High
$6.35
52W Low
$1.10

MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
0.43
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
-1.53
EV/Revenue (<3 favorable)
191913.54
P/S (TTM) (<3 favorable)
563.62
P/B (<3 favorable)
7.92
Ownership
Retail‑heavy
Source: Overview
Insiders (1–5% typical)
24.12%
Institutions (25–75% balanced)
10.57%
Shares Outstanding
41,570,200
Float
28,647,600
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
455
Gross Profit (TTM)
158,830
EPS (TTM)
-1.90
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
N/A
ROE (TTM) (>15% strong)
-1.31%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
-1.00
Momentum
Bearish momentum
Value
1.2824
Previous
1.1572
Trend
Rising
Signal Cross
No cross

As of
Sep. 12, 2025